Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00721617 · ClinicalTrials.gov registry record · NA

FFA Hypertension and Inflammation in Lean and Obese Subjects

A NA study of Obesity and Hypertension, sponsored by Emory University.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT00721617 is a NA study of Obesity and Hypertension that has completed, run by Emory University. The registered enrollment target is 12 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00721617, a NA study of Obesity and Hypertension, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Although a large number of obese patients develop high blood pressure, the cause is unknown. The purpose of this study is to look at the effect of high fatty acids (a type of fat) in the development of high blood pressure in obese people.

Interventions

  • OTHER Normal Saline
  • OTHER Intralipid 20%
  • OTHER Oral fat load

Study Locations (1)

Georgia

  • Grady Memorial Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2009-04
Est. Completion 2011-06
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT00721617

The ClinicalTrials.gov registry entry for NCT00721617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Normal Saline is the first listed.

NCT00721617 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00721617 about?

NCT00721617 is a clinical study titled "FFA Hypertension and Inflammation in Lean and Obese Subjects". Although a large number of obese patients develop high blood pressure, the cause is unknown. The purpose of this study is to look at the effect of high fatty acids (a type of fat) in the development of high blood pressure in obese people.

What is the current status of trial NCT00721617?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-04. Estimated completion is 2011-06.

What conditions does trial NCT00721617 study?

This clinical trial studies the following conditions: Obesity, Hypertension, Diabetes.

What interventions are being tested in trial NCT00721617?

The interventions under investigation include: Normal Saline (OTHER), Intralipid 20% (OTHER), Oral fat load (OTHER).

Who is sponsoring clinical trial NCT00721617?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00721617 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.